Since a decrease, and not an increase, in calretinin expression is associated with the poorest overall survival, this may suggest that, if it is indeed HuR that stabilizes calretinin mRNA, it competes to bind other tumor progression-associated targets. Here, CALB2 is linked to neoplasm.